<bill session="114" type="h" number="3012" updated="2017-06-02T21:25:37Z">
  <state datetime="2015-07-09">REFERRED</state>
  <status>
    <introduced datetime="2015-07-09"/>
  </status>
  <introduced datetime="2015-07-09"/>
  <titles>
    <title type="short" as="introduced">Right to Try Act of 2015</title>
    <title type="official" as="introduced">To authorize the use of unapproved medical products by patients diagnosed with a terminal illness in accordance with State law, and for other purposes.</title>
    <title type="display">Right to Try Act of 2015</title>
  </titles>
  <sponsor id="400606"/>
  <cosponsors>
    <cosponsor id="412625" joined="2016-06-24"/>
    <cosponsor id="412541" joined="2016-07-14"/>
    <cosponsor id="400018" joined="2016-06-24"/>
    <cosponsor id="412635" joined="2016-06-14"/>
    <cosponsor id="412478" joined="2016-09-07"/>
    <cosponsor id="400033" joined="2015-09-29"/>
    <cosponsor id="400636" joined="2016-04-18"/>
    <cosponsor id="412605" joined="2016-04-12"/>
    <cosponsor id="412395" joined="2016-09-07"/>
    <cosponsor id="412258" joined="2016-11-15"/>
    <cosponsor id="412470" joined="2016-05-11"/>
    <cosponsor id="412271" joined="2016-06-28"/>
    <cosponsor id="412236" joined="2016-06-21"/>
    <cosponsor id="412555" joined="2016-02-01"/>
    <cosponsor id="400124" joined="2016-11-14"/>
    <cosponsor id="400646" joined="2016-03-07"/>
    <cosponsor id="400141" joined="2016-02-01"/>
    <cosponsor id="400145" joined="2016-07-13"/>
    <cosponsor id="400651" joined="2016-04-12"/>
    <cosponsor id="412397" joined="2015-07-09"/>
    <cosponsor id="412388" joined="2016-05-24"/>
    <cosponsor id="412661" joined="2016-02-26"/>
    <cosponsor id="412444" joined="2016-07-14"/>
    <cosponsor id="412623" joined="2016-06-24"/>
    <cosponsor id="412609" joined="2016-07-06"/>
    <cosponsor id="400195" joined="2016-07-13"/>
    <cosponsor id="400196" joined="2016-07-12"/>
    <cosponsor id="400220" joined="2016-03-07"/>
    <cosponsor id="412510" joined="2016-06-24"/>
    <cosponsor id="412191" joined="2016-04-15"/>
    <cosponsor id="412290" joined="2016-06-15"/>
    <cosponsor id="400245" joined="2016-09-20"/>
    <cosponsor id="412656" joined="2016-05-26"/>
    <cosponsor id="412294" joined="2016-07-07"/>
    <cosponsor id="412295" joined="2016-04-29"/>
    <cosponsor id="412611" joined="2016-04-19"/>
    <cosponsor id="412552" joined="2016-06-24"/>
    <cosponsor id="412560" joined="2016-11-14"/>
    <cosponsor id="412540" joined="2016-02-23"/>
    <cosponsor id="412474" joined="2016-06-21"/>
    <cosponsor id="412302" joined="2016-02-23"/>
    <cosponsor id="412443" joined="2016-07-14"/>
    <cosponsor id="412608" joined="2016-02-24"/>
    <cosponsor id="400316" joined="2016-06-24"/>
    <cosponsor id="412551" joined="2016-07-06"/>
    <cosponsor id="412393" joined="2016-07-18"/>
    <cosponsor id="412394" joined="2016-06-24"/>
    <cosponsor id="412310" joined="2016-06-24"/>
    <cosponsor id="400343" joined="2016-05-11"/>
    <cosponsor id="412426" joined="2016-07-06"/>
    <cosponsor id="412641" joined="2016-06-21"/>
    <cosponsor id="400607" joined="2016-06-24"/>
    <cosponsor id="412399" joined="2016-02-24"/>
    <cosponsor id="400365" joined="2016-05-19"/>
    <cosponsor id="412581" joined="2016-04-25"/>
    <cosponsor id="412392" joined="2015-07-09"/>
    <cosponsor id="412670" joined="2016-06-24"/>
    <cosponsor id="412564" joined="2016-07-11"/>
    <cosponsor id="412610" joined="2016-04-12"/>
    <cosponsor id="412525" joined="2016-06-24"/>
    <cosponsor id="412428" joined="2016-03-07"/>
  </cosponsors>
  <actions>
    <action datetime="2015-07-09">
      <text>Introduced in House</text>
    </action>
    <action datetime="2015-07-09" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2015-07-09">
      <text>Referred to House Energy and Commerce</text>
    </action>
    <action datetime="2015-07-09">
      <text>Referred to House Judiciary</text>
    </action>
    <action datetime="2015-07-10">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2015-07-29">
      <text>Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSJU" name="House Judiciary" activity="Referral"/>
    <committee activity="Referral" code="HSJU08" subcommittee="Crime, Terrorism, Homeland Security, and Investigations" name="House Judiciary"/>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee activity="Referral" code="HSIF14" subcommittee="Health" name="House Energy and Commerce"/>
  </committees>
  <relatedbills>
    <bill relation="unknown" session="114" type="s" number="2912"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Drug therapy"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Long-term, rehabilitative, and terminal care"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2015-07-09T04:00:00Z" status="Introduced in House">Right to Try Act of 2015

Bars the federal government from prohibiting or restricting the production, manufacture, distribution, prescribing, dispensing, possession, or use of an experimental drug, biological product, or device that is: (1) intended to treat a patient who has been diagnosed with a terminal illness; and (2) authorized by, and in accordance with, state law.

Defines an "experimental drug, biological product, or device" as one that: (1) has successfully completed a phase 1 clinical investigation; (2) remains under investigation in a clinical trial approved by the Food and Drug Administration; and (3) is not approved, licensed, or cleared for commercial distribution under the Federal Food, Drug, or Cosmetic Act or the Public Health Service Act.</summary>
  <committee-reports/>
</bill>
